Fibroblastic Colony-Forming Unit Bone Marrow Cells Delay Progression to Gastric Dysplasia in aHelicobacterModel of Gastric Tumorigenesis
- 9 July 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 27 (9) , 2301-2311
- https://doi.org/10.1002/stem.165
Abstract
Bone marrow mesenchymal stem cells (MSCs) have been shown to have immune modulatory effects. Despite efforts to identify these cells in vivo, to date,Keywords
Funding Information
- National Institutes of Health (5R01 CA120979-02)
- Canadian Institute of Health Research and Albert Heritage Foundation for Medic Research
This publication has 58 references indexed in Scilit:
- IL‐17 is Involved in Helicobacter pylori‐Induced Gastric Inflammatory Responses in a Mouse ModelHelicobacter, 2008
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Stem Cell Therapy for Liver Disease: Parameters Governing the Success of Using Bone Marrow Mesenchymal Stem CellsGastroenterology, 2008
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt functionNature, 2008
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences, 2007
- Inflammation, atrophy, and gastric cancerJournal of Clinical Investigation, 2007
- IL-23 plays a key role inHelicobacter hepaticus–induced T cell–dependent colitisThe Journal of Experimental Medicine, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotypeImmunity, 1994